Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2016 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program.
Carlin JB, Macartney KK, Lee KJ, Quinn HE, Buttery J, Lopert R, Bines J, McIntyre PB. Carlin JB, et al. Clin Infect Dis. 2013 Nov;57(10):1427-34. doi: 10.1093/cid/cit520. Epub 2013 Aug 26. Clin Infect Dis. 2013. PMID: 23964090
BACKGROUND: Estimates of the risk of intussusception (IS) associated with currently licensed rotavirus vaccines (RV1 [Rotarix; GSK] and RV5 [RotaTeq; Merck]) diverge. ...Self-controlled case series and case-control methods were used to as …
BACKGROUND: Estimates of the risk of intussusception (IS) associated with currently licensed rotavirus vaccin
Intussusception and Monovalent Rotavirus Vaccination in Singapore: Self-Controlled Case Series and Risk-Benefit Study.
Yung CF, Chan SP, Soh S, Tan A, Thoon KC. Yung CF, et al. J Pediatr. 2015 Jul;167(1):163-8.e1. doi: 10.1016/j.jpeds.2015.03.038. Epub 2015 Apr 14. J Pediatr. 2015. PMID: 25882872
To perform risk-benefit analysis of RV1 vaccination programs in Singapore. STUDY DESIGN: We performed a self-controlled case series by extracting intussusception cases in infants aged <12 months from hospital databases (2005-2012) and with vaccination hist …
To perform risk-benefit analysis of RV1 vaccination programs in Singapore. STUDY DESIGN: We performed a self-controlled case s …
Rotavirus vaccination and intussusception - Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries.
Yen C, Healy K, Tate JE, Parashar UD, Bines J, Neuzil K, Santosham M, Steele AD. Yen C, et al. Hum Vaccin Immunother. 2016 Oct 2;12(10):2580-2589. doi: 10.1080/21645515.2016.1197452. Epub 2016 Jun 20. Hum Vaccin Immunother. 2016. PMID: 27322835 Free PMC article. Review.
As of January 2016, 80 countries have introduced rotavirus vaccines into their national immunization programs. Many have documented significant declines in rotavirus-specific and all-cause diarrheal illnesses following vaccine introductio …
As of January 2016, 80 countries have introduced rotavirus vaccines into their national immunization programs